Longevity Therapeutics is organized by Hanson Wade and will be held from Jan 29 - 31, 2019 at Argonaut Hotel, San Francisco, California, United States of America.
This Conference will bring together the leading biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative therapies targeting age-related conditions.
Join them to collaboratively tackle specific challenges faced to develop these therapies – from discovery, to preclinical activities, translational research, clinical development, regulatory and commercial considerations – and uncover the details behind the latest developments in this space.
Aubrey de Grey - AgeX Therapeutics, Judith Campisi - Buck Institute for Research on Aging, Nathaniel David - Unity Biotechnology, Nir Barzilai - Albert Einstein College of Medicine, Samuel Agus - Biophytis, Steven Braithwaite - Alkahest Inc., Ronald Kohanski - National Institute on Aging, NIH, Mark Bamberger - Stealth BioTherapeutics, Marc Ramis-Castelltort - Senolytic Therapeutics Inc., Lorna Harries - University of Exeter Medical School, Lindsay Wu - UNSW Sydney, Life Biosciences, Kristen Fortney - BioAge Labs, Kelsey Moody - Antoxerene/Ichor Therapeutics
Time: 8:00 am - 5:00 pm
Pre-Conference Workshop will be held on Jan 29, 2019
Additional details will be posted as soon as they are available.
|Registration Type||End Date||Price|
|Conference Only Early Fee||16 Nov,2018||USD 1899.00|
|Conference Only Standard Fee||28 Jan,2019||USD 2099.00|
|Conference Workshop Early Fee||16 Nov,2018||USD 2398.00|
|Conference Workshop Standard Fee||28 Jan,2019||USD 2598.00|